---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-010146"
form_type: "8-K"
ticker: null
cik: "0001838821"
company_name: "ARYA Sciences Acquisition Corp IV"
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T09:27:00.678711+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ARYA Sciences SPAC gets Nasdaq delisting notice for failing to complete business combination within 36 months

## Summary
- Received Nasdaq staff notice on Feb 26, 2024 for non-compliance with IM-5101-2 (36-month deadline).
- Trading would be suspended March 6, 2024 unless hearing timely requested by March 4, 2024.
- ARYA has requested a hearing before Nasdaq Hearings Panel to stay suspension and complete business combination with Adagio Medical, Inc.
- No assurance ARYA will regain compliance or maintain Nasdaq listing.

## SEC filing metadata
- accession: 0001140361-24-010146
- form_type: 8-K
- cik: 0001838821
- company_name: ARYA Sciences Acquisition Corp IV
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1838821/000114036124010146/0001140361-24-010146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1838821/000114036124010146/ny20020899x12_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-010146
- JSON: https://secwatch.observer/filing/0001140361-24-010146.json
- Plain text: https://secwatch.observer/filing/0001140361-24-010146.txt

## Key facts
- Listing & Compliance Notices
  ARYA Sciences Acquisition Corp IV received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: IM-5101-2
  source text: February 26, 2024, ARYA Sciences Acquisition Corp IV (“ARYA”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, unless ARYA timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”) by March 4, 2024, trading of ARYA’s securities on the Nasdaq Capital Market would be suspended at the opening of business on March 6, 2024, due to ARYA’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1838821/000114036124010146/0001140361-24-010146-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.